ATLANTA, GA – – (Newsfile Corp. – April 28, 2022) – – Holzer & Holzer, LLC is investigating whether Teladoc Health, Inc. (“Teladoc” or the “Company”) (NYSE: TDOC) complied with federal securities laws. On April 27, 2022, Teladoc reported first quarter financial results for the quarter ended March 31, 2022. The Company announced it was revising and lowering its 2022 outlook due to a “lower-than-expected yield” on the Company’s marketing spend and a net loss per share of $41.58, which was attributed to a “non-cash goodwill impairment charge of $6.6 billion.” Following this announcement, the Company’s stock price dropped. If you purchased Teladoc stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at email@example.com or Joshua Karr, Esq. at firstname.lastname@example.org, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com to discuss your legal rights.